Clinical Trial Update: Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing immediate versus extended-release tacrolimus in lung transplant patients to reduce calcineurin inhibitor-related toxicity; status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplant

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Heleen Grootjans | Conditions: Lung Transplant; Complications | Phase 3 | Status: UNKNOWN